Independent Public Teaching Hospital No. 4 in Lublin

Lublin 20-954

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Non-small Cell Lung Cancer

Studies at this site

• Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed